4//SEC Filing
Pamir Ozan 4
Accession 0001213900-23-041328
CIK 0001690080other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:30 AM ET
Size
5.1 KB
Accession
0001213900-23-041328
Insider Transaction Report
Form 4
Pamir Ozan
Interim CFO
Transactions
- Purchase
Common Stock
2023-05-18$1.01/sh+5,162.077$5,214→ 8,983.077 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.9801 to $1.02, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001834681
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 8:30 AM ET
- Size
- 5.1 KB